|
1
|
Coward JI, Middleton K and Murphy F: New
perspectives on targeted therapy in ovarian cancer. Int J Womens
Health. 7:189–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iyoke CA and Ugwu GO: Burden of
gynaecological cancers in developing countries. World J Obstet
Gynecol. 2:1–7. 2013. View Article : Google Scholar
|
|
3
|
Rauh-Hain JA, Krivak TC, Del Carmen MG and
Olawaiye AB: Ovarian cancer screening and early detection in the
general population. Rev Obstet Gynecol. 4:15–21. 2011.PubMed/NCBI
|
|
4
|
Goff B: Symptoms associated with ovarian
cancer. Clin Obstet Gynecol. 55:36–42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaku T, Ogawa S, Kawano Y, Ohishi Y,
Kobayashi H, Hirakawa T and Nakano H: Histological classification
of ovarian cancer. Med Electron Microsc. 36:9–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leong HS, Galletta L, Etemadmoghadam D,
George J; Australian Ovarian Cancer Study, ; Köbel M, Ramus SJ and
Bowtell D: Efficient molecular subtype classification of high-grade
serous ovarian cancer. J Pathol. 236:272–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Köbel M, Kalloger SE, Boyd N, McKinney S,
Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, et al:
Ovarian carcinoma subtypes are different diseases: Implications for
biomarker studies. PLoS Med. 5:e2322008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Canney PA, Moore M, Wilkinson PM and James
RD: Ovarian cancer antigen CA125: A prospective clinical assessment
of its role as a tumour marker. Br J Cancer. 50:765–769. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pepin K, Carmen MD, Brown A and Dizon DS:
CA 125 and epithelial ovarian cancer: Role in screening, diagnosis,
and surveillance. Am J Hematol Oncol. 10:22–29. 2014.
|
|
10
|
Mitra SK and Schlaepfer DD:
Integrin-regulated FAK-Src signaling in normal and cancer cells.
Curr Opin Cell Biol. 18:516–523. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Judson PL, He X, Cance WG and Van Le L:
Overexpression of focal adhesion kinase, a protein tyrosine kinase,
in ovarian carcinoma. Cancer. 86:1551–1556. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li M, Hong LI, Liao M and Guo G:
Expression and clinical significance of focal adhesion kinase and
adrenomedullin in epithelial ovarian cancer. Oncol Lett.
10:1003–1007. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sood AK, Coffin JE, Schneider GB, Fletcher
MS, DeYoung BR, Gruman LM, Gershenson DM, Schaller MD and Hendrix
MJ: Biological significance of focal adhesion kinase in ovarian
cancer: Role in migration and invasion. Am J Pathol. 165:1087–1095.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao X and Guan JL: Focal adhesion kinase
and its signaling pathways in cell migration and angiogenesis. Adv
Drug Deliv Rev. 63:610–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hall JE, Fu W and Schaller MD: Focal
adhesion kinase: Exploring Fak structure to gain insight into
function. Int Rev Cell Mol Biol. 288:185–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lim ST: Nuclear FAK: A new mode of gene
regulation from cellular adhesions. Mol Cells. 36:1–6. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dixon RD, Chen Y, Ding F, Khare SD,
Prutzman KC, Schaller MD, Campbell SL and Dokholyan NV: New
insights into FAK signaling and localization based on detection of
a FAT domain folding intermediate. Structure. 12:2161–2171. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schaller MD, Borgman CA and Parsons JT:
Autonomous expression of a noncatalytic domain of the focal
adhesion-associated protein tyrosine kinase pp125FAK. Mol Cell
Biol. 13:785–791. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Toutant M, Costa A, Studler J, Kadaré G,
Carnaud M and Girault JA: Alternative splicing controls the
mechanisms of FAK autophosphorylation. Mol Cell Biol. 22:7731–7743.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Contestabile A, Bonanomi D, Burgaya F,
Girault JA and Valtorta F: Localization of focal adhesion kinase
isoforms in cells of the central nervous system. Int J Dev
Neurosci. 21:83–93. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Corsi JM, Rouer E, Girault JA and Enslen
H: Organization and post-transcriptional processing of focal
adhesion kinase gene. BMC Genomics. 7:1982006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Despeaux M, Chicanne G, Rouer E, De
Toni-Costes F, Bertrand J, Mansat-De Mas V, Vergnolle N, Eaves C,
Payrastre B, Girault JA and Racaud-Sultan C: Focal adhesion kinase
splice variants maintain primitive acute myeloid leukemia cells
through altered Wnt signaling. Stem Cells. 30:1597–1610. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grisaru-Granovsky S, Salah Z, Maoz M,
Pruss D, Beller U and Bar-Shavit R: Differential expression of
protease activated receptor 1 (Par1) and pY397FAK in benign and
malignant human ovarian tissue samples. Int J Cancer. 113:372–378.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lark AL, Livasy CA, Dressler L, Moore DT,
Millikan RC, Geradts J, Iacocca M, Cowan D, Little D, Craven RJ and
Cance W: High focal adhesion kinase expression in invasive breast
carcinomas is associated with an aggressive phenotype. Mod Pathol.
18:1289–1294. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hidalgo A, Piña P, Guerrero G, Lazos M and
Salcedo M: A simple method for the construction of small format
tissue arrays. J Clin Pathol. 56:144–146. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Allred DC, Harvey JM, Berardo M and Clark
GM: Prognostic and predictive factors in breast cancer by
immunohistochemical analysis. Mod Pathol. 11:155–168.
1998.PubMed/NCBI
|
|
27
|
Fogh J: Human tumor cells in vitro. Plenum
Press; New York: pp. 115–141. 1975
|
|
28
|
Hamilton TC, Young RC, Mckoy WM,
Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR
and Ozols RF: Characterization of a human ovarian carcinoma cell
line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer
Res. 43:5379–5389. 1983.PubMed/NCBI
|
|
29
|
Provencher DM, Lounis H, Champoux L,
Tétrault M, Manderson EN, Wang JC, Eydoux P, Savoie R, Tonin PN and
Mes-Masson AM: Characterization of four novel epithelial ovarian
cancer cell lines. In Vitro Cell Dev Biol Anim. 36:357–361. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McCormack SJ, Brazinski SE, Moore JL Jr,
Werness BA and Goldstein DJ: Activation of the focal adhesion
kinase signal transduction pathway in cervical carcinoma cell lines
and human genital epithelial cells immortalized with human
papillomavirus type 18. Oncogene. 15:265–274. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pizon M, Schott DS, Pachmann U and
Pachmann K: B7-H3 on circulating epithelial tumor cells correlates
with the proliferation marker, Ki-67, and may be associated with
the aggressiveness of tumors in breast cancer patients. Int J
Oncol. 53:2289–2299. 2018.PubMed/NCBI
|
|
32
|
Xu LH, Yang X, Craven RJ and Cance WG: The
COOH-terminal domain of the focal adhesion kinase induces loss of
adhesion and cell death in human tumor cells. Cell Growth Differ.
9:999–1005. 1998.PubMed/NCBI
|
|
33
|
Parsons JT: Focal adhesion kinase: The
first ten years. J Cell Sci. 116:1409–1416. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Albasri A, Fadhil W, Scholefield JH,
Durrant LG and Ilyas M: Nuclear expression of phosphorylated focal
adhesion kinase is associated with poor prognosis in human
colorectal cancer. Anticancer Res. 34:3969–3974. 2014.PubMed/NCBI
|
|
35
|
Toutant M, Studler JM, Burgaya F, Costa A,
Ezan P, Gelman M and Girault JA: Autophosphorylation of Tyr397 and
its phosphorylation by Src-family kinases are altered in
focal-adhesion-kinase neuronal isoforms. Biochem J. 348:119–128.
2000. View Article : Google Scholar : PubMed/NCBI
|
